A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United States, according to new research. The national study, led by physician-scientists at Sylvester Comprehensive ...
Apr 30, 2026
0
7
T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from healthy ones. Now, scientists ...
Mar 10, 2026
0
16
Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate. Patients often relapse after receiving initial therapy, making it especially challenging for clinicians to ...
Dec 8, 2025
0
5
A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell therapy for multiple myeloma, ...
Aug 21, 2025
0
42
T-follicular helper (TFH) lymphoma is a blood cancer subgroup that continues to demonstrate a generally poor prognosis, with no standard treatment established to date. Although specific genetic mutations are frequently observed ...
Jun 10, 2025
0
12
Northwestern Medicine investigators have discovered how the protein PD-1 controls essential metabolic processes in tumor cells to promote cancer growth in T-cell non-Hodgkin lymphomas (T-NHLs), according to a study published ...
Sep 21, 2023
0
40
The age-adjusted incidence rate of anaplastic large-cell lymphoma (ALCL) of the breast is increasing rapidly in the United States, according to a research letter published online July 21 in JAMA Oncology.
Jul 26, 2022
0
38
